( NASDAQ-NMS:LMNX )

News from Luminex Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 14, 2017, 16:05 ET Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held...


Oct 31, 2017, 16:05 ET Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Group A Strep Assay, a moderate complexity,...


Oct 30, 2017, 16:05 ET Luminex Corporation Reports Third Quarter 2017 Financial Results

Luminex Corporation (Nasdaq: LMNX) today announced financial results for the third quarter of 2017. Financial and operating highlights for the...


Oct 09, 2017, 16:05 ET Luminex Corporation Third Quarter Earnings Release Scheduled for October 30, 2017

Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2017 on Monday,...


Sep 19, 2017, 16:05 ET Luminex Corporation To Present At Cantor Fitzgerald's Global Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's Global Healthcare Conference to be held...


Sep 12, 2017, 08:30 ET Luminex Corporation Declares Third Quarter Cash Dividend

Luminex Corporation (NASDAQ:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the third quarter of...


Aug 29, 2017, 08:30 ET Luminex Corporation and Sutter Health Collaborate to Improve Patient Care

Luminex Corporation (NASDAQ: LMNX), and Sutter Health, a not-for-profit health system in Northern California, today announced a collaboration to...


Aug 07, 2017, 16:05 ET Luminex Corporation Reports Second Quarter 2017 Financial Results

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the second quarter of 2017. Financial and operating highlights for the...


Jul 24, 2017, 08:30 ET Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® C. difficile Assay, a moderate complexity,...


Jul 17, 2017, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for August 7, 2017

Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2017 on Monday, August...


Jun 28, 2017, 08:00 ET Luminex Corporation erhält CE-IVD-Kennzeichnung für ARIES® Norovirus Assay

Einfach anzuwendendes Sample-to-Answer-Assay ermöglicht schnellen Nachweis für Hauptauslöser der akuten Gastroenteritis Die Luminex...


Jun 28, 2017, 08:00 ET Luminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for the ARIES® Norovirus Assay, an easy to use, sample to...


Jun 28, 2017, 08:00 ET Luminex Corporation obtient la marque CE-IVD pour l'essai de Norovirus ARIES®

Facile à utiliser, l'essai d'échantillon-à-réponse permet de détecter rapidement la cause principale de gastroentérite aiguë La société...


Jun 05, 2017, 08:00 ET Luminex Corporation's VERIGENE Gram-Positive and Gram-Negative Blood Culture Panels Receive Reimbursement Approval in Japan

Luminex Corporation (NASDAQ: LMNX) today announced that Japan's Central Social Insurance Medical Council has approved the recommendation by the...


May 25, 2017, 08:30 ET Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Jefferies 2017 Global Healthcare Conference on Thursday,...


May 24, 2017, 08:30 ET Luminex Corporation Declares Second Quarter Cash Dividend

Luminex Corporation (NASDAQ:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the second quarter of...


May 03, 2017, 08:00 ET Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Bordetella Assay for direct detection and...


May 01, 2017, 16:05 ET Luminex Corporation Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the first quarter of 2017. Financial and operating highlights for the...


Apr 26, 2017, 08:30 ET Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference on...


Apr 20, 2017, 08:30 ET Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Bank of America Merrill Lynch 2017 Health Care Conference on...


Apr 10, 2017, 16:05 ET Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017

Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the first quarter ended March 31, 2017 on Monday, May 1,...


Feb 21, 2017, 16:05 ET Luminex Corporation Announces Initiation of Cash Dividend

Luminex Corporation (NASDAQ: LMNX) (the "Company") today announced that its board of directors has authorized the initiation of a quarterly cash...


Feb 06, 2017, 16:05 ET Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full year 2016 ended December 31, 2016. Financial...


Jan 09, 2017, 08:30 ET Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and...


Jan 04, 2017, 08:00 ET Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Group B Streptococcus (GBS) Assay for...